The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | B | Blood and blood forming organs | |
| 2 | B02 | Antihemorrhagics | |
| 3 | B02B | Vitamin K and other hemostatics | |
| 4 | B02BD | Blood coagulation factors | |
| 5 | B02BD08 | Eptacog alfa (activated) |
| Active Ingredient | Description | |
|---|---|---|
| Coagulation factor VIIa |
Pharmacological doses of rFVIIa activate factor X directly on the surface of activated platelets, localized to the site of injury, independently of tissue factor. This results in the conversion of prothrombin into large amounts of thrombin independently of tissue factor. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CEVENFACTA Powder and solvent for solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| NOVOSEVEN Powder and solvent for solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
